Subtle Medical Enters UK Market to Drive Faster, Higher Quality MRI with SubtleHD™

AI-powered MRI enhancement now available to UK providers to improve scan speed, image quality, and operational efficiency

MENLO PARK, Calif., Nov. 4, 2025 /PRNewswire/ — Subtle Medical, the market leader in AI-powered image acceleration and enhancement, today announced that it has received EU MDR CE Marking and successfully registered to enter the United Kingdom market. With this milestone, SubtleHD™ is now commercially available across the UK.

UK imaging services continue to face growing demand and resource pressures.  SubtleHD helps imaging teams boost efficiency and image quality through a vendor-neutral software solution that deploys easily with existing scanners, optimising performance and reducing wait times without additional hardware.

SubtleHD™ uses deep learning to enhance MRI image quality beyond standard of care and accelerate up to 80% faster scan acquisition, helping radiology providers reduce MRI backlogs, increase usage on currently operating magnets, and improve the patient experience with shorter scan times. As a vendor-neutral software, SubtleHD integrates seamlessly into current workflows and extends the life and performance of existing MRI scanners, a significant advantage in markets where access to new imaging equipment may be limited.

“Our entry into the UK market marks an exciting step in Subtle Medical’s global growth,” said Josh Gurewitz, Chief Commercial Officer of Subtle Medical. “We’re proud to bring SubtleHD’s proven technology to more radiology departments and imaging providers, helping them achieve higher-quality imaging and more efficient operations through AI innovation.”

Subtle Medical’s AI solutions for MRI and PET are currently deployed in over one thousand hospitals and imaging centers worldwide, supporting radiology teams in improving image quality, accelerating scans, and optimizing patient care.

About Subtle Medical
Subtle Medical is a leading provider of AI-powered imaging solutions, optimizing scan efficiency and image quality across radiology. Recognized by TIME as a World’s Top Healthcare Company (2025) and multiple times as a CB Insights GenAI 50, Digital Health 150, and Top AI 100 company, Subtle Medical is committed to transforming medical imaging through responsible and intelligent software. The company’s solutions are deployed on over 1000 scanners worldwide, helping imaging centers and hospitals deliver faster scans, improve image quality, and enhance patient care without the need for new hardware. Learn more at www.subtlemedical.com.

Media Contact:
Anna Menyhart-Borroni
Head of Global Marketing
anna@subtlemedical.com

References:
RCR News
NHS GIRFT
Nuffield Trust

View original content to download multimedia:https://www.prnewswire.com/news-releases/subtle-medical-enters-uk-market-to-drive-faster-higher-quality-mri-with-subtlehd-302603604.html

SOURCE Subtle Medical, Inc.

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

6 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

11 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

12 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

12 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

12 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

17 hours ago